Survival Study Of Oncophage® vs. Observation In Patients With Kidney Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

650

Participants

Timeline

Start Date

June 30, 2000

Primary Completion Date

April 30, 2007

Study Completion Date

April 30, 2007

Conditions
Renal Cell Carcinoma
Interventions
DRUG

autologous human tumor-derived HSPPC-96

Trial Locations (76)

21287

Baltimore

55905

Rochester

70056

Gretna

Unknown

Anchorage

Tucson

Los Angeles

San Francisco

Denver

Farmington

Boca Raton

Miami

Tampa

Atlanta

Chicago

Maywood

Iowa City

Kansas City

Boston

St Louis

Albuquerque

Manhasset

New York

Rochester

Charlotte

Winston-Salem

Cincinnati

Cleveland

Columbus

Eugene

Portland

Philadelphia

Knoxville

Nashville

Fort Worth

Houston

South Burlington

Richmond

Seattle

Milwaukee

Vienna

Kortrijk

Liège

Calgary

Vancouver

Victoria

London

Toronto

Montreal

Québec

Lille

Strasbourg

Toulouse

Villejuif

Beer-Yaacob

Haifa

Holon

Jerusalem

Tel Litwinsky

Oslo

Stavanger

Bialystok

Gdansk

Kielce

Krakow

Lublin

Szczecin

Warsaw

Barcelona

Madrid

Valencia

Gothenburg

Lund

Umeå

Uppsala

Bristol

London

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Agenus Inc.

INDUSTRY